您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览0

Genome-wide association studies have identified several germline single nucleotide polymorphisms (SNPs) significantly associated with colorectal cancer (CRC) incidence. Common germline genetic variation may also be related to CRC survival. We used a discovery-based approach to identify SNPs related to survival outcomes after CRC diagnosis. Genome-wide genotyping arrays were conducted for 3494 individuals with invasive CRC enrolled in six prospective cohort studies (median study-specific follow-up = 4.2-8.1 years). In pooled analyses, we used Cox regression to assess SNP-specific associations with CRC-specific and overall survival, with additional analyses stratified by stage at diagnosis. Top findings were followed-up in independent studies. A P value threshold of P < 5×10(-8) in analyses combining discovery and follow-up studies was required for genome-wide significance. Among individuals with distant-metastatic CRC, several SNPs at 6p12.1, nearest the ELOVL5 gene, were statistically significantly associated with poorer survival, with the strongest associations noted for rs209489 [hazard ratio (HR) = 1.8, P = 7.6×10(-10) and HR = 1.8, P = 3.7×10(-9) for CRC-specific and overall survival, respectively). No SNPs were statistically significantly associated with survival among all cases combined or in cases without distant-metastases. SNPs in 6p12.1/ELOVL5 were associated with survival outcomes in individuals with distant-metastatic CRC, and merit further follow-up for functional significance. Findings from this genome-wide association study highlight the potential importance of genetic variation in CRC prognosis and provide clues to genomic regions of potential interest.

作者:Amanda I, Phipps;Michael N, Passarelli;Andrew T, Chan;Tabitha A, Harrison;Jihyoun, Jeon;Carolyn M, Hutter;Sonja I, Berndt;Hermann, Brenner;Bette J, Caan;Peter T, Campbell;Jenny, Chang-Claude;Stephen J, Chanock;Jeremy P, Cheadle;Keith R, Curtis;David, Duggan;David, Fisher;Charles S, Fuchs;Manish, Gala;Edward L, Giovannucci;Richard B, Hayes;Michael, Hoffmeister;Li, Hsu;Eric J, Jacobs;Lina, Jansen;Richard, Kaplan;Elisabeth J, Kap;Timothy S, Maughan;John D, Potter;Robert E, Schoen;Daniela, Seminara;Martha L, Slattery;Hannah, West;Emily, White;Ulrike, Peters;Polly A, Newcomb

来源:Carcinogenesis 2016 年 37卷 1期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:0
作者:
Amanda I, Phipps;Michael N, Passarelli;Andrew T, Chan;Tabitha A, Harrison;Jihyoun, Jeon;Carolyn M, Hutter;Sonja I, Berndt;Hermann, Brenner;Bette J, Caan;Peter T, Campbell;Jenny, Chang-Claude;Stephen J, Chanock;Jeremy P, Cheadle;Keith R, Curtis;David, Duggan;David, Fisher;Charles S, Fuchs;Manish, Gala;Edward L, Giovannucci;Richard B, Hayes;Michael, Hoffmeister;Li, Hsu;Eric J, Jacobs;Lina, Jansen;Richard, Kaplan;Elisabeth J, Kap;Timothy S, Maughan;John D, Potter;Robert E, Schoen;Daniela, Seminara;Martha L, Slattery;Hannah, West;Emily, White;Ulrike, Peters;Polly A, Newcomb
来源:
Carcinogenesis 2016 年 37卷 1期
Genome-wide association studies have identified several germline single nucleotide polymorphisms (SNPs) significantly associated with colorectal cancer (CRC) incidence. Common germline genetic variation may also be related to CRC survival. We used a discovery-based approach to identify SNPs related to survival outcomes after CRC diagnosis. Genome-wide genotyping arrays were conducted for 3494 individuals with invasive CRC enrolled in six prospective cohort studies (median study-specific follow-up = 4.2-8.1 years). In pooled analyses, we used Cox regression to assess SNP-specific associations with CRC-specific and overall survival, with additional analyses stratified by stage at diagnosis. Top findings were followed-up in independent studies. A P value threshold of P < 5×10(-8) in analyses combining discovery and follow-up studies was required for genome-wide significance. Among individuals with distant-metastatic CRC, several SNPs at 6p12.1, nearest the ELOVL5 gene, were statistically significantly associated with poorer survival, with the strongest associations noted for rs209489 [hazard ratio (HR) = 1.8, P = 7.6×10(-10) and HR = 1.8, P = 3.7×10(-9) for CRC-specific and overall survival, respectively). No SNPs were statistically significantly associated with survival among all cases combined or in cases without distant-metastases. SNPs in 6p12.1/ELOVL5 were associated with survival outcomes in individuals with distant-metastatic CRC, and merit further follow-up for functional significance. Findings from this genome-wide association study highlight the potential importance of genetic variation in CRC prognosis and provide clues to genomic regions of potential interest.